Aidoc vs Regard AI
In-depth comparison — valuation, funding, investors, founders & more
🇮🇱 Israel · Elad Walach
Valuation
N/A
Total Funding
$370M
300 employees
🇺🇸 United States
Valuation
N/A
Total Funding
$30M
50-200 employees
Analyst Summary
Generated from real data · No AI hallucinations
Both Aidoc and Regard AI compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Aidoc is an Israeli artificial intelligence company founded in 2016 that develops clinical decision support software for radiology and medical imaging. Regard AI builds an AI clinical documentation assistant that integrates with hospital electronic health record systems to automatically identify potential diagnoses, surface relevant clinical evidence from patient records, and generate structured documentation for physician review.
Neither company has publicly disclosed a valuation at this time. On the funding side, Aidoc has raised $370M in total — $340M more than Regard AI's $30M.
Aidoc has 1 year more market experience, having been founded in 2016 compared to Regard AI's 2017 founding. In terms of growth stage, Aidoc is at Series D while Regard AI is at Series B — a meaningful difference for investors evaluating risk and upside.
Aidoc operates out of 🇮🇱 Israel while Regard AI is based in 🇺🇸 United States, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, Aidoc leads with a score of 67, reflecting stronger overall fundamentals across valuation, funding, and growth signals.
Metrics Comparison
| Metric | Aidoc | Regard AI |
|---|---|---|
💰Valuation | N/A | N/A |
📈Total Funding | $370MWINS | $30M |
📅Founded | 2016 | 2017WINS |
🚀Stage | Series D | Series B |
👥Employees | 300 | 50-200 |
🌍Country | Israel | United States |
🏷️Category | AI Healthcare | AI Healthcare |
⭐Awaira Score | 67WINS | 55 |
Key Differences
Funding gap: Aidoc has raised $340M more ($370M vs $30M)
Market experience: Aidoc has 1 year more (founded 2016 vs 2017)
Growth stage: Aidoc is at Series D vs Regard AI at Series B
Team size: Aidoc has 300 employees vs Regard AI's 50-200
Market base: 🇮🇱 Aidoc (Israel) vs 🇺🇸 Regard AI (United States)
Direct competitors: Both operate in the AI Healthcare market segment
Awaira Score: Aidoc scores 67/100 vs Regard AI's 55/100
Which Should You Choose?
Use these signals to make the right call
Choose Aidoc if…
Top Pick- ✓Higher Awaira Score — 67/100 vs 55/100
- ✓Stronger investor backing — raised $370M
- ✓More market experience — founded in 2016
- ✓Israel-based for regional compliance or proximity
- ✓Aidoc is an Israeli artificial intelligence company founded in 2016 that develops clinical decision support software for radiology and medical imaging
Choose Regard AI if…
- ✓United States-based for regional compliance or proximity
- ✓Regard AI builds an AI clinical documentation assistant that integrates with hospital electronic health record systems to automatically identify potential diagnoses, surface relevant clinical evidence from patient records, and generate structured documentation for physician review
Funding History
Aidoc raised $370M across 8 rounds. Regard AI raised $30M across 0 rounds.
Aidoc
Series D
Dec 2021
Lead: Insight Partners
Series D
Jun 2021
Lead: Macquarie Group
Series C
Sep 2020
Lead: Khosla Ventures
Series C
Sep 2020
Lead: Ibex Investors
Series B
Jan 2019
Lead: GE Ventures
Series B
Jan 2019
Lead: Khosla Ventures
Series A
Jan 2018
Series A
Jan 2018
Lead: Pitango VC
Regard AI
No public funding data available.
Investor Comparison
No shared investors detected between these two companies.
Unique to Aidoc